1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Lymphangiomyoma: new trials by email Literature Review of Lymphangiomyoma trials Research Report on Lymphangiomyoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial Sirolimus - LAM, Lymphangioleiomyomatosis | Phase 3 | Active not recruiting | University of Cincinnati | 60 | 2018-01-01 | 2024-12-24 |
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Neoplasm, Lymphatic Tissue (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Connective and Soft Tissue (1) · Perivascular Epithelioid Cell Neoplasms (1)
Sirolimus (1)
United States (1)
Francis X. McCormack, M.D. (1)
U01HL131755 (1)